ASPPH logo


Member Research & Reports

Member Research & Reports

Georgia State Study Finds Stroke Registry Improves Patient Care

Stroke patients who received care from hospitals in Georgia’s stroke registry had better survival outcomes than those who were admitted to non-participating hospitals, according to a new study co-authored by researchers at Georgia State University’s School of Public Health.

The study, led by Dr. Ike S. Okosun at the School of Public Health and his PhD student Dr. Moges Seyoum Ido, found that participation in the Georgia Coverdell Acute Stroke Registry (GCASR) was linked with lower death rates for patients in the year following treatment for acute ischemic stroke (stroke caused by a clot or blockage).

The study, “Administrative Data Linkage to Evaluate a Quality Improvement Program in Acute Stroke Care, Georgia, 2006–2009” was published recently in the journal Preventing Chronic Disease.

The authors wrote that the study “demonstrated that a state-based initiative based on the collaborative effort of professionals who are willing to share their expertise and exchange best practices results in tangible benefit to the community served.”

GCASR is a part of a national stroke registry program, the Paul Coverdell National Acute Stroke Registry, which aims to improve acute stroke care nationwide with the goal of reducing the rate of death and disability due to stroke. Hospitals enrolled in GCASR were defined as those actively taking part in quality improvement efforts for stroke care, as well as data entry through the program.

The study analyzed Georgia hospital discharge and death data and found the data sets could be effectively linked to assess the impact of clinical-level or community-level initiative for chronic disease care.

Dr. Ido is also an epidemiologist at the Georgia Department of Public Health. The other co-authors of the study are Dr. Rodney Lyn of the School of Public Health at Georgia State University, Ms. Rana Bayakly of the Georgia Department of Public Health, and Dr. Michael Frankel, a professor of neurology at Emory University School of Medicine.

To read the complete report, go to: – Author Information